VanEck Biotech ETF Company Overview

VanEck Biotech ETF logo
VanEck Biotech ETF
VanEck Biotech ETF primary media

About VanEck Biotech ETF

VanEck Biotech ETF (NASDAQ:BBH) operates as an exchange-traded fund (ETF) focusing on the biotechnology industry. This ETF seeks to provide investment results that, before fees and expenses, correspond generally to the price and yield performance of its underlying index, which includes companies primarily engaged in the research, development, manufacturing, and distribution of various biotechnological products. Their projects and objectives revolve around tracking an index composed of firms at the forefront of medical and technological innovations in the biotech sector, aiming to offer investors diversified exposure to this dynamic industry. The VanEck Biotech ETF is traded exclusively on the NASDAQ, ensuring a straightforward investment process for individuals interested in tapping into the biotechnology market's potential.

What is VanEck Biotech ETF known for?

Snapshot

2011
Year founded
305
Employees
New York, United States
Head office
Loading Map...

Operations

All Locations
New York City, US

Produtos e/ou serviços de VanEck Biotech ETF

  • Investment in leading biotechnology companies for capital appreciation.
  • Portfolio diversification across various biotech segments including therapeutics and diagnostics.
  • Active management to navigate the volatile biotech sector.
  • Research and analysis for identifying promising biotech innovations.
  • Risk management strategies tailored for the biotech industry's unique challenges.
  • Offering exposure to emerging biotech markets and companies.

equipe executiva do VanEck Biotech ETF

    Connect with us

    Disclaimer

    Grafa is not a financial advisor. You should seek independent, legal, financial, taxation or other advice that relate to your unique circumstances.

    Grafa is not liable for any loss caused, whether due to negligence or otherwise arising from the use of or reliance on the information provided directly or indirectly, by use of this platform.